Jump to main content
Jump to site search
PLANNED MAINTENANCE Close the message box

Scheduled maintenance upgrade on Thursday 4th of May 2017 from 8.00am to 9.00am (BST).

During this time our websites will be offline temporarily. If you have any questions please use the feedback button on this page. We apologise for any inconvenience this might cause and thank you for your patience.


Issue 12, 2016
Previous Article Next Article

Small molecule-mediated protein knockdown as a new approach to drug discovery

Author affiliations

Abstract

The concept of using peptidic bifunctional molecules to allow recruitment of ubiquitin E3 ligases to induce the degradation of specific intracellular proteins was first demonstrated in 2001 but, following the extension of this approach to non-peptidic agents, its utility has been greatly expanded. As the number of E3 ligases amenable to recruitment also continues to grow, induced protein degradation now represents a new pharmacological strategy for highly efficient chemical protein knockdown with utility both as a chemical biology tool and also potentially as a clinically-useful therapeutic modality. We survey some of the recent advances in the design of small molecule chemical inducers of protein degradation and the potential challenges that will need to be overcome in order to allow clinical evaluation.

Graphical abstract: Small molecule-mediated protein knockdown as a new approach to drug discovery

Back to tab navigation
Please wait while Download options loads

Publication details

The article was received on 23 Jun 2016, accepted on 24 Jul 2016 and first published on 26 Jul 2016


Article type: Review Article
DOI: 10.1039/C6MD00347H
Citation: Med. Chem. Commun., 2016,7, 2206-2216
  •   Request permissions

    Small molecule-mediated protein knockdown as a new approach to drug discovery

    C. P. Tinworth, H. Lithgow and I. Churcher, Med. Chem. Commun., 2016, 7, 2206
    DOI: 10.1039/C6MD00347H

Search articles by author